NewGenIvf: Acquired 13,000 SOL and approved a $2 million stock repurchase plan

The Nasdaq-listed Solana treasury company NewGenIvf disclosed in its latest financial report that it has purchased 13,000.23 SOL and participated in a $100 million gold-backed asset tokenization project.

The financial report shows that NewGenIvf achieved a net profit of $17.5 million in the third quarter. The company's board also approved a 24-month stock repurchase plan with a scale of $2 million.